DUBLIN - May 7, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the appointment of Mike Weinstein as Senior Vice President, Strategy. In this role, Weinstein will work with Medtronic senior management in the areas of strategy, business development, capital deployment, and shareholder value creation.
Weinstein joins Medtronic from J.P. Morgan Chase & Co., where he served as a Managing Director and led the firm's top-ranked healthcare team in equity research for more than 20 years.
"We are excited to welcome Mike to Medtronic," said Omar Ishrak, Medtronic chairman and chief executive officer. "He is deeply respected within the industry and brings with him vast knowledge of our markets, technologies, and growth strategies. I look forward to his contributions to the company, including his expert guidance and insights, as well as the new perspective he will bring to our organization."
Weinstein joined J.P. Morgan in 1992 and had been the firm's senior medical technology analyst since 1995. He has been the #1 ranked analyst in the sector for the past 15 years in annual surveys of Institutional Investor and Greenwich Associates. In 2013, he was named to the Institutional Investor Hall of Fame.
"I see in Medtronic the opportunity to continue to create significant shareholder value, and I couldn't be more excited to join the global leader in medical technology and contribute to its Mission," said Weinstein. "Having covered Medtronic for more than two decades now, I have full confidence in the outlook and the strategy, and our ability to unlock that value in the months and years ahead."
"Mike brings unique and deep insights of the medical device and technology space to Medtronic, developed during a distinguished career in equity research at J.P. Morgan," said Karen Parkhill, Medtronic executive vice president and chief financial officer. "He will serve as an integral advisor and partner to our senior leaders, and we are thrilled to welcome him to the team."
Weinstein assumes his position at Medtronic effective immediately and will report to Parkhill.
Medtronic will host a webcast on Monday, May 7, at 7:00 a.m. CDT to discuss this announcement. The webcast can be accessed at http://investorrelations.medtronic.com. Within 24 hours of the webcast, a replay will be available by clicking on the Investor Events link at http://investorrelations.medtronic.com.
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 84,000 people worldwide, serving physicians, hospitals and patients in approximately 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.